Arbutus Biopharma Corp (ABUS) insider trading
Every open-market stock purchase and sale by Arbutus Biopharma Corp executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: Viking Global Performance LLC (10% owner), $66.4M, 8 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales). Last close $4.18 on Oct 21, 2026.
Recent ABUS insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 1, 2026 | Tuan Nguyen (CFO) | Sold (not open market) | $240K |
| Oct 1, 2026 | Lindsay Androski (CEO) | Sold (not open market) | $123K |
| Oct 1, 2026 | Robert A Beardsley (Director) | Sold (not open market) | $89.7K |
| Oct 1, 2026 | Roger Sawhney (Director) | Sold (not open market) | $85.7K |
| Sep 18, 2026 | Tuan Nguyen (CFO) | Sold (not open market) | $1M |
| Sep 18, 2026 | Roger Sawhney (Director) | Sold (not open market) | $510K |
| Sep 18, 2026 | Robert A Beardsley (Director) | Sold (not open market) | $502K |
| Sep 18, 2026 | Lindsay Androski (CEO) | Sold (not open market) | $418K |
| Sep 18, 2026 | Tuan Nguyen (CFO) | Bought (not open market) | — |
| Sep 18, 2026 | Lindsay Androski (CEO) | Bought (not open market) | — |
| Sep 18, 2026 | Lindsay Androski (CEO) | Bought (not open market) | — |
| Sep 18, 2026 | Tuan Nguyen (CFO) | Bought (not open market) | — |
| Sep 18, 2026 | Roger Sawhney (Director) | Bought (not open market) | — |
| Sep 18, 2026 | Roger Sawhney (Director) | Bought (not open market) | — |
| Sep 18, 2026 | Robert A Beardsley (Director) | Bought (not open market) | — |
| Sep 18, 2026 | Robert A Beardsley (Director) | Bought (not open market) | — |
| Jun 8, 2026 | Robert A Beardsley (Director) | Bought (not open market) | — |
| Jun 8, 2026 | Roger Sawhney (Director) | Bought (not open market) | — |
| Feb 2, 2026 | Tuan Nguyen (CFO) | Bought (not open market) | — |
| Feb 2, 2026 | Tuan Nguyen (CFO) | Bought (not open market) | — |
| Feb 2, 2026 | Lindsay Androski (CEO) | Bought (not open market) | — |
| Feb 2, 2026 | Lindsay Androski (CEO) | Bought (not open market) | — |
Who's trading ABUS
- Lindsay Androski, CEO: other filings, last Oct 1, 2026
- Robert A Beardsley, Director: other filings, last Oct 1, 2026
- Roger Sawhney, Director: other filings, last Oct 1, 2026
- Tuan Nguyen, CFO: other filings, last Oct 1, 2026
Get free alerts when an insider at Arbutus Biopharma Corp files a new trade →